author-photo

David A. Krupa

Merck & Co.

21

Papers

1003

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Onset of pain relief with rofecoxib in chronic low back pain: results of two four-week, randomized, placebo-controlled trials

2004 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (43)
Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs*

2004 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (22)
Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.

2003 Spine
Show All
- Source
- Cite
- Save
Citations (60)
A Comparison of Adverse Renovascular Experiences Among Osteoarthritis Patients Treated with Rofecoxib and Comparator Non-selective Non-steroidal Anti-inflammatory Agents

2002 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (39)
Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.

2001 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (77)
Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.

2001 The Journal of Rheumatology
Show All
- Source
- Cite
- Save
Citations (25)
(211) A Placebo‐Controlled Trial of Rofecoxib in the Treatment of Chronic Low Back Pain

2001 Pain Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone–insulin‐like growth factor I axis in growth hormone–deficient children

2001 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (24)
Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal*

2000 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (107)
Characterization of GH secretory ability of GH deficient children: Response to MK-0677

1998 Growth Hormone & Igf Research
Show All
- Source
- Cite
- Save
Citations (1)